Cancer, diabetes, survival and glycemic control: a large multisite analysis

Author:

Karlin Nina J1ORCID,Kosiorek Heidi E2ORCID,Verona Patricia M3ORCID,Coppola Kyle E4ORCID,Cook Curtiss B5ORCID

Affiliation:

1. Division of Hematology & Medical Oncology, Mayo Clinic, Phoenix, Arizona, USA

2. Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA

3. Information Technology, Mayo Clinic, Phoenix, Arizona, USA

4. Cancer Registry, Mayo Clinic, Scottsdale, Arizona, USA

5. Division of Endocrinology, Mayo Clinic, Scottsdale, Arizona, USA

Abstract

Aim: To determine overall survival (OS) and glycemic control in patients with cancer and diabetes. Materials & methods: Patients of our institution with breast, colon, lung, pancreas and prostate cancer were retrospectively reviewed. OS was compared between matched patients with and without diabetes, and changes in glucose value over time were assessed. Results: For 3934 patients each with and without diabetes, adjusted analysis showed no difference in OS according to diabetes status (hazard ratio: 1.07; 95% CI: 0.96–1.20). Mean glucose values decreased over time in patients with and without diabetes (p = 0.01). Conclusion: In this large study of patients with five common cancers, the co-occurrence of diabetes did not affect OS. Cancer did not adversely affect glucose levels.

Publisher

Future Science Ltd

Subject

Biotechnology

Reference23 articles.

1. Centers for Disease Control and Prevention. National Diabetes Statistics Report 2020 (2020). http://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf

2. Centers for Disease Control and Prevention. United States Cancer Statistics: prevalence (2021). https://gis.cdc.gov/Cancer/USCS/#/Prevalence/

3. Centers for Disease Control and Prevention. Changes Over Time: All Types of Cancer (2021). https://gis.cdc.gov/Cancer/USCS/#/Trends/

4. Cancer with Diabetes: Prevalence, Metabolic Control, and Survival in an Academic Oncology Practice

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3